Aims/hypothesis Obesity is a major risk factor for type 2 diabetes, but little is known about the contribution of BMIassociated loci to type 2 diabetes risk in East Asian populations. Methods In this study, 30 known BMI-associated variants and a genetic risk score (GRS) calculated by summing the BMIincreasing alleles of these variants were tested for associations with type 2 diabetes and related glycaemic traits in 1,873 cases of type 2 diabetes and 1,839 controls in Han Chinese individuals. Logistic and linear regression analyses were performed to determine the association with type 2 diabetes risk or related glycaemic traits, respectively, under an additive model with or without adjustment for BMI. ) in the overall population. Each additional BMI-increasing allele in the GRS increased type 2 diabetes risk by 1.029-fold (95% CI 1.008, 1.050; p=0.0056) without adjustment for BMI, and the association was slightly attenuated after adjustment for BMI (OR 1.022; 95% CI 1.002, 1.043; p=0.035). In non-diabetic controls, the GRS was also associated with HOMA of beta cell function (HOMA-B) with adjustment for BMI (β [SE] −0.876 [0.345]; p=0.011). Notably, the association of GRS with type 2 diabetes was abolished after adjusting for HOMA-B (OR 1.012; 95% CI 0.986, 1.039; p=0.380). Conclusions/interpretation Our results suggested that genetic predisposition to obesity leads to increased risk of type 2 diabetes, independent of BMI and partly through impaired beta cell function.
Introduction
Obesity is a major risk factor for type 2 diabetes. Genomewide association studies (GWAS) have identified 38 loci convincingly associated with BMI in populations with European, Asian and African ancestry [1] [2] [3] . Recent studies in Europeans have demonstrated that the genetic susceptibility to obesity leads to increased risk of type 2 diabetes, through its obesity-increasing effect [4] . However, these studies did not include the most recently identified loci. Moreover, the BMI-associated loci may act differently in Asians and Europeans, since their adiposity phenotype and genetic background differ. For example, the FTO locus confers type 2 diabetes risk through its effect on BMI in Europeans, whereas in East Asians, the association remains after adjusting for BMI [5] . Therefore, it is of interest to test whether the genetic predisposition to obesity also contributes to type 2 diabetes risk through its effect on BMI in Han Chinese individuals. In this case-control study of 3,712 unrelated Han Chinese, we examined the association of a genetic risk score (GRS), based on 38 BMI-associated single-nucleotide polymorphisms (SNPs), with type 2 diabetes and glycaemic traits, and whether BMI mediated the association.
Methods
Study population Our analyses included 3,975 individuals (1,999 type 2 diabetes cases and 1,976 controls) from four studies. Full details of study populations, design, protocols and biochemical measurements have been described previously [6] . BMI was calculated as weight/height 2 (kg/m 2 ). Indices of insulin sensitivity (HOMA-S) and beta cell function (HOMA-B) were estimated by the homeostasis model using Levy's computer model (www.dtu.ox.ac.uk/homacalculator/download.php, 20 February 2014). The criteria for type 2 diabetes cases and non-diabetic controls are shown in the electronic supplementary material (ESM) Table 1. All studies were approved by local ethic committees, and informed written consent was obtained from all participants.
Genotyping After excluding the samples (n=263) who had call rate <97% and less than three SNPs with missing genotypes, 1,873 cases and 1,839 controls were included in this study (ESM Table 2 ). To date, 38 BMI-related loci have been identified in GWAS with p<5×10 −8 , of which eight are monomorphic in Han Chinese individuals [1] [2] [3] . Therefore, a total of 30 BMI-associated SNPs representing independent loci were included in this study. Even though the vast majority of these SNPs were first identified in populations of Europeans, most SNPs have also shown associations with BMI in East Asian populations [1, 2] . Yet, because of differences in linkage disequilibrium structure between East Asians and other ancestry populations, the selected SNPs may not always be the ones that show the strongest association in East Asians and thus could lower the statistical power. Genotyping and imputation have been described elsewhere [6] . Briefly, DNA samples were genotyped using the Illumina Human660W-Quad BeadChip (Illumina, San Diego, CA, USA Table 3 ).
Statistical analyses Due to the non-normal distribution, values of insulin and HOMA-S were natural log-transformed before analyses. We calculated the unweighted GRS of each individual by summing the number of BMI-increasing alleles [1] [2] [3] of the 30 SNPs. The weighted GRS was calculated by weighting each BMI-increasing allele with the ratio of its reported β-coefficient to the sum of all SNPs' β-coefficients [1] [2] [3] , and summing these values. ; ESM Table 4 ). Each additional BMI-increasing allele of the unweighted GRS was significantly associated with a 1.029-fold increased risk of type 2 diabetes (95% CI 1.008, 1.050; p=0.0056), adjusted for age, sex and region, and further adjustment for BMI only slightly attenuated the association (OR 1.022; 95% CI 1.002, 1.043; p=0.035; Table 1 ). Individually, BMIincreasing alleles of 21 SNPs were in the direction of associations with increased type 2 diabetes risk without adjustment for BMI ( p=0.021 for binomial test) and four were nominally associated with increased type 2 diabetes risk (ESM Table 5 ). However, the BMI-increasing allele of CDKAL1-rs9356744 was significantly associated with decreased risk of type 2 diabetes (OR 0.72; 95% CI 0.66, 0.95; p=2.63×10 ) with or without adjustment for BMI (ESM Table 5 ). After removing the six SNPs that showed associations with type 2 diabetes individually, the association between the GRS and type 2 diabetes risk remained unchanged, suggesting that the association was not driven by one or a few loci.
The GRS was nominally associated with lower HOMA-B after adjusting for BMI (β [SE] −0.876 [0.345]; p=0.011; Table 2 ). Individually, eight SNPs showed nominal associations with glycaemic traits, but only the association between GALNT10-rs7708584 and HbA 1c value remained significant after Bonferroni correction (ESM Table 6 ). Notably, further adjustment for HOMA-B abolished the association between GRS and type 2 diabetes (OR 1.012; 95% CI 0.986, 1.039; p= 0.380; Table 1 ) and excluding the participants who were receiving glucose-lowering treatment did not change the results (OR 1.01; 95% CI 0.93, 1.10; p=0.79). Similar results were observed for the weighted GRS (ESM Table 7 ). The triangular relationship between the GRS, BMI and type 2 diabetes also suggested that the association might be mediated through impaired beta cell function (ESM Fig. 2 ).
Discussion
In this type 2 diabetes case-control study of Han Chinese, we found that each additional BMI-increasing allele in the GRS was associated with about a 3% increased risk for type 2 diabetes, independent of BMI. In the non-diabetic controls, the BMI GRS was associated with lower HOMA-B after adjusting for BMI. The association of the GRS with type 2 diabetes was abolished after controlling for HOMA-B.
Similarly, previous studies in European populations have found that each additional BMI-increasing allele increased the OR of type 2 diabetes by 3-4% [4] . However, in Chinese Hans, unlike Europeans, the effect of GRS on type 2 diabetes seemed to be mediated by HOMA-B rather than by BMI. One Table 2 Associations of BMI GRS with glycaemic traits in non-diabetic controls Our results also showed that BMI GRS was nominally associated with decreased HOMA-B, which was independent of BMI. Moreover, analysis of the triangular relationship between the GRS, HOMA-B and type 2 diabetes, using GRS as an instrumental variable, also suggested that HOMA-B mediated, at least partially, the association between the GRS and type 2 diabetes. Although previous findings from GWAS of type 2 diabetes emphasised the importance of beta cell function in the development of type 2 diabetes [7] , the exact mechanisms underlying the effects of the BMI loci on HOMA-B and type 2 diabetes remain unknown.
Individually, most SNPs showed directionally consistent effects on type 2 diabetes risk, as in Europeans [4] , and only the BMI-increasing allele of CDKAL1-rs9356744 was significantly associated with decreased risk of type 2 diabetes. Consistently, a recent GWAS of BMI in East Asians also found that the BMI-decreasing allele of this SNP was associated with increased type 2 diabetes risk [1] .
Our study had sufficient statistical power (≥80%) to detect associations of the GRS with BMI and type 2 diabetes risk, but it generally lacked power to replicate previously reported associations with BMI for most SNPs individually. Therefore, our primary analyses focus on the GRS analyses. Nevertheless, large-scale meta-analyses in East Asians have confirmed the single-SNP associations for most of the SNPs studied here [1, 2] .
In summary, we concluded that the GRS for obesity also confers type 2 diabetes risk in Han Chinese individuals, and that its effect on type 2 diabetes is partly mediated through impaired beta cell function but is independent of BMI.
